Brain : a journal of neurology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Brain morphometry in former American football players: Findings from the DIAGNOSE CTE research project..
147:3596-3610.
2024
-
Autoimmune 'secondary synaptopathies': do NMDAR antibodies cause a primary extra-synaptopathy?.
147:2601-2603.
2024
-
Parkinson's disease variant detection and disclosure: PD GENEration, a North American study..
147:2668-2679.
2024
-
Towards cascading genetic risk in Alzheimer's disease..
147:2680-2690.
2024
-
Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease..
147:2144-2157.
2024
-
Macroscopic changes in aquaporin-4 underlie blast traumatic brain injury-related impairment in glymphatic function..
147:2214-2229.
2024
-
Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease..
147:2158-2168.
2024
-
Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains..
147:1680-1695.
2024
-
Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females..
147:1497-1510.
2024
-
Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics..
146:4414-4424.
2023
-
Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis..
146:4508-4519.
2023
-
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis..
146:3719-3734.
2023
-
Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's disease..
146:2928-2943.
2023
-
Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression..
146:2944-2956.
2023
-
Tau positron emission tomography in preclinical Alzheimer's disease..
146:700-711.
2023
-
Temporopolar regions of the human brain..
146:20-41.
2023
-
Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan..
145:4459-4473.
2022
-
Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes..
145:4506-4518.
2022
-
Sex-specific effects of microglial activation on Alzheimer's disease proteinopathy in older adults..
145:3536-3545.
2022
-
Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline..
145:2823-2833.
2022
-
A calcium-sensitive antibody isolates soluble amyloid-β aggregates and fibrils from Alzheimer's disease brain..
145:2528-2540.
2022
-
Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease..
145:2541-2554.
2022
-
Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease..
145:2149-2160.
2022
-
Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia..
145:2133-2148.
2022
-
Cortical and subcortical pathological burden and neuronal loss in an autopsy series of FTLD-TDP-type C..
145:1069-1078.
2022
-
Proposed research criteria for prodromal behavioural variant frontotemporal dementia..
145:1079-1097.
2022
-
Impact of autism genetic risk on brain connectivity: a mechanism for the female protective effect..
145:378-387.
2022
-
COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital..
144:2696-2708.
2021
-
Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulation..
144:2837-2851.
2021
-
Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's disease..
144:2852-2862.
2021
-
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease..
144:2186-2198.
2021
-
The development and convergence of co-pathologies in Alzheimer's disease..
144:953-962.
2021
-
CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease..
144:515-527.
2021
-
18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome..
144:266-277.
2021
-
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain..
143:3816-3826.
2020
-
Lowering the risk of Parkinson's disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes..
143:2868-2871.
2020
-
Genetic variants and functional pathways associated with resilience to Alzheimer's disease..
143:2561-2575.
2020
-
Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau..
143:932-943.
2020
-
Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy..
143:611-621.
2020
-
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age..
143:320-335.
2020
-
Postoperative delirium is associated with increased plasma neurofilament light..
143:47-54.
2020
-
Sex differences in the genetic predictors of Alzheimer's pathology..
142:2581-2589.
2019
-
Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease..
142:2380-2401.
2019
-
Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies..
142:2068-2081.
2019
-
Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects..
142:1148-1160.
2019
-
Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression..
142:1077-1092.
2019
-
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers..
142:1063-1076.
2019
-
Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration..
142:460-470.
2019
-
Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing function..
141:-.
2018
-
Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype..
141:1828-1839.
2018
-
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing..
141:1486-1500.
2018
-
TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis..
141:1320-1333.
2018
-
FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis..
141:1201-1217.
2018
-
Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease..
140:3301-3316.
2017
-
Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels..
140:2104-2111.
2017
-
Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder..
140:-.
2017
-
A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction..
140:1128-1146.
2017
-
Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism..
140:98-117.
2016
-
Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia..
139:3202-3216.
2016
-
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease..
139:2766-2777.
2016
-
Neural substrates of vulnerability to post-surgical delirium with prospective diagnosis..
139:-.
2016
-
Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife..
139:2261-74.
2016
-
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging..
139:2249-60.
2016
-
Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice..
139:2063-81.
2016
-
Neural substrates of vulnerability to postsurgical delirium as revealed by presurgical diffusion MRI..
139:1282-94.
2016
-
Reply: Neural substrates of vulnerability to post-surgical delirium with prospective diagnosis..
139:-.
2016
-
Free-water imaging in Parkinson's disease and atypical parkinsonism..
139:495-508.
2015
-
TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF..
138:3610-22.
2015
-
Seizures at the scale of individual neurons..
138:2807-8.
2015
-
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects..
138:2701-15.
2015
-
The Wernicke conundrum and the anatomy of language comprehension in primary progressive aphasia..
138:2423-37.
2015
-
Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression..
138:1023-35.
2015
-
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study..
138:963-73.
2015
-
Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease..
138:2659-71.
2015
-
Identification of the SCA21 disease gene: remaining challenges and promising opportunities..
137:2626-8.
2014
-
Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline..
137:1167-75.
2014
-
Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia..
137:1176-92.
2014
-
A novel frontal pathway underlies verbal fluency in primary progressive aphasia..
136:2619-28.
2013
-
In vivo characterization of the early states of the amyloid-beta network..
136:2239-52.
2013
-
A cortical pathway to olfactory naming: evidence from primary progressive aphasia..
136:1245-59.
2013
-
Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy..
136:926-43.
2013
-
Words and objects at the tip of the left temporal lobe in primary progressive aphasia..
136:601-18.
2013
-
Quantitative classification of primary progressive aphasia at early and mild impairment stages..
135:1537-53.
2012
-
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia..
135:1554-65.
2012
-
Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β..
135:2155-68.
2012
-
Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden..
134:1635-46.
2011
-
Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment..
134:1077-88.
2011
-
Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury..
135:1268-80.
2011
-
Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease..
133:1352-67.
2010
-
Relationship of dementia screening tests with biomarkers of Alzheimer's disease..
133:3290-300.
2010
-
Biomarkers for Alzheimer's disease: ready for the next step..
132:2002-4.
2009
-
Neurology of anomia in the semantic variant of primary progressive aphasia..
132:2553-65.
2009
-
'The quicksand of forgetfulness': semantic dementia in One hundred years of solitude..
132:2609-16.
2009
-
Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology..
131:109-19.
2007
-
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations..
130:1767-76.
2007
-
Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study..
129:3103-14.
2006
-
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease..
129:2867-73.
2006
-
Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury..
127:2629-35.
2004
-
Brain responses to nouns, verbs and class-ambiguous words in context..
2552-66.
2000
-
Mirth, laughter and gelastic seizures..
757-80.
1993
-
In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease
2013
Identity
International Standard Serial Number (ISSN)